Llama antibodies: New therapeutic avenues against schizophrenia
- Details
- Category: Research
Scientists at the Institute of Functional Genomics (CNRS/Inserm/Université de Montpellier) have just designed a nanobody made from llama antibodies that can specifically activate a glutamate receptor involved in regulating neural activity.
Surprising finding could pave way for universal cancer vaccine
- Details
- Category: Research
Published in Nature Biomedical Engineering, the University of Florida study showed that like a one-two punch, pairing the test vaccine with common anticancer drugs called immune checkpoint inhibitors triggered a strong antitumor response.
New chemical tool may improve development of key drug components
- Details
- Category: Research
Typically used in chemical reactions essential for drug synthesis and materials development, carbenes are short-lived, highly reactive carbon atoms.
Stevia leaf extract has potential as anticancer treatment
- Details
- Category: Research
The researchers published their findings in the International Journal of Molecular Sciences.
Taking the sting out of ulcerative colitis
- Details
- Category: Research
Make - your - own weight - loss drug using an innovative genome editing approach
- Details
- Category: Research
In a study published in Communications Medicine, researchers from The University of Osaka have revealed that a modified genome editing approach to tackle noncommunicable, multifaceted diseases.
Common autoimmune drug may help reverse immunotherapy - induced diabetes
- Details
- Category: Research
The study, published in JCI Insight, identifies a new group of immune cells involved in the development immune checkpoint inhibitor - induced type 1 diabetes and shows that JAK inhibitors,
More Pharma News ...
- Researchers discover new way cells protect themselves from damage
- Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks
- Researchers develop potent CDK9 inhibitor to overcome drug resistance in hematological malignancies
- Research opens up new avenue for tuberculosis drug discovery
- Aggressive skin cancer driven by mitochondrial processes - existing drugs offer promising treatment path
- Study highlights major hurdles for multinational clinical trials in Europe
- New model to find treatments for an aggressive blood cancer